Collaborating to Advance Health Equity for Diabetes and Chronic Kidney Disease - M-CERSI Conference
Thursday, January 21, 2021
8:00 a.m.-5:00 p.m.
U.S. Food and Drug Administration, White Oak Campus, Silver Spring MD
** This event has been postponed to January 21, 2020. **
Scheduled for Thursday, January 21, 2021, "Collaborating to Advance Health Equity for Diabetes and Chronic Kidney Disease" will bring together researchers from across academia, government, and industry to advance our understanding of the unique interplay of biological, genetic, environmental, socio-cultural, and health care system level factors that may prompt reorientation of our approach to health promotion and disease prevention, improve patient outcomes and reduce health inequities for patients with diabetes and chronic kidney disease.
The event will take place from 8:00 until 5:00 p.m. at the U.S. Food and Drug Administration's White Oak Campus, located at 10903 New Hampshire Avenue in Silver Spring, MD.
About the Event:
Kidney disease and diabetes are an intertwined topic that augments the need for discussions that are comprehensive and inclusive of all populations. This effort supports the executive order on Advancing Kidney Health (released July 2019) by bringing together federal partners, clinicians, and the academic sector to address this timely issue.
The workshop will be open to public.
This workshop supports the Office of Minority Health and Health Equity's (OMHHE) mission, as well as the 21st Century Cures Act to understand patient perspectives. Through understanding patient perspectives, including perspectives from minority and vulnerable populations around the topic of diabetes and CKD, this workshop further supports U.S. Food and Drug Administration's (FDA) efforts to incorporate the perspectives of patients into its decision-making process.
In addition, this workshop supports the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA section 907), an effort to advance inclusion of racial and ethnic minority populations in clinical trials.
Visit this page for more event information including an agenda, and parking for the event.
This workshop is supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award U01FD005946 totaling $5,000 with 100 percent funded by FDA/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by FDA/HHS, or the U.S. Government.